Abstract
Although it is considered rare, stimulant-induced psychosis is one of the most serious and unpleasant adverse events during attention deficit/hyperactivity disorder (ADHD) treatment. There is a need to update regularly the current state of knowledge on this topic to improve quality of care. For this reason, we reviewed relevant publications using Pubmed database, for the period 2003-2012. It came out that the amount of publications, which are predominantly case reports, on this topic are limited for this period. Previous trend of publication and state of knowledge continues. Newer atypical antipsychotics, which complicate stimulant treatment in ADHD, is an emerging dimension. We suggest more research and ongoing clinical vigilance to reach an advanced understanding of the topic.
Keywords: Adverse effect, ADHD, CNS stimulant drugs, drug-induced psychosis, mania, methylphenidate, psychoactive drugs.
Current Psychopharmacology
Title:Stimulant-Related Psychosis in ADHD Treatment: An Update for Past 10 Years
Volume: 2
Author(s): Gresa C. Bulut, Seheryeli Y. Kaynar and Osman Sabuncuoglu
Affiliation:
Keywords: Adverse effect, ADHD, CNS stimulant drugs, drug-induced psychosis, mania, methylphenidate, psychoactive drugs.
Abstract: Although it is considered rare, stimulant-induced psychosis is one of the most serious and unpleasant adverse events during attention deficit/hyperactivity disorder (ADHD) treatment. There is a need to update regularly the current state of knowledge on this topic to improve quality of care. For this reason, we reviewed relevant publications using Pubmed database, for the period 2003-2012. It came out that the amount of publications, which are predominantly case reports, on this topic are limited for this period. Previous trend of publication and state of knowledge continues. Newer atypical antipsychotics, which complicate stimulant treatment in ADHD, is an emerging dimension. We suggest more research and ongoing clinical vigilance to reach an advanced understanding of the topic.
Export Options
About this article
Cite this article as:
Bulut C. Gresa, Kaynar Y. Seheryeli and Sabuncuoglu Osman, Stimulant-Related Psychosis in ADHD Treatment: An Update for Past 10 Years, Current Psychopharmacology 2013; 2 (3) . https://dx.doi.org/10.2174/22115560113029990005
DOI https://dx.doi.org/10.2174/22115560113029990005 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ascorbic acid-Catalyzed One-Pot Three-Component Biginelli Reaction: A Practical and Green Approach towards Synthesis of 3,4-dihydropyrimidin- 2(1H)-ones/thiones
Letters in Organic Chemistry Editorial (Hot Topic: Matrix Metalloproteinases: Drug Targets in Cardiovascular Diseases)
Current Drug Targets Activation of the Renin-angiotensin System could Cause Hypertension During Fasting in Muslims in the Month of Ramadhan
Current Hypertension Reviews Clinical Potential of VIP by Modified Pharmaco-kinetics and Delivery Mechanisms
Endocrine, Metabolic & Immune Disorders - Drug Targets Pulmonary Hypertension: Current Therapy and Future Prospects
Cardiovascular & Hematological Agents in Medicinal Chemistry Neonatal Persistent Pulmonary Hypertension Associated with Congenital Cystic Adenomatoid Malformation Treated with Sildenafil: Case Report
Current Pediatric Reviews Amyloid A Amyloidosis Secondary to Rheumatoid Arthritis: An Uncommon Yet Important Complication
Current Rheumatology Reviews Preparation of A Magnetic Nanosensor Based on Cobalt Ferrite Nanoparticles for The Electrochemical Determination of Methyldopa in The Presence of Uric Acid
Combinatorial Chemistry & High Throughput Screening Diabetes, the Renin-Angiotensin System and Heart Disease
Current Vascular Pharmacology Implications of Angiotensin II in Central Nervous System on Exercise Performance
Current Protein & Peptide Science How to Treat Patients with Essential Hypertension and Peripheral Arterial Disease
Current Pharmaceutical Design Nanomaterial Based Approaches for the Diagnosis and Therapy of Cardiovascular Diseases
Current Pharmaceutical Design Molecular Mechanisms of Several Novel Dipeptides with Angiotensin-Iconverting Enzyme Inhibitory Activity from In-silico Screening of Silkworm Pupae Protein
Current Pharmaceutical Biotechnology The Possible Potency of Ocimum basilicum New Constituent on Glucosestimulated Insulin Secretion In Vitro and β-cell Function In Vivo
Letters in Drug Design & Discovery Restless Legs Syndrome/Willis-Ekbom Disease and Periodic Limb Movements: A Comprehensive Review of Epidemiology, Pathophysiology, Diagnosis and Treatment Considerations
Current Rheumatology Reviews Optimizing the Management of Uncontrolled Hypertension: What do Triple Fixed-Dose Drug Combinations Add?
Current Vascular Pharmacology Cognitive Impairment and Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Progression of Renal Dysfunction in Patients with Cardiovascular Disease
Current Cardiology Reviews Reviewing the Cardiovascular Complications of HIV Infection After the Introduction of Highly Active Antiretroviral Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Subject Index To Volume 7
Current Drug Targets